Scoring Systems for Estimating the Risk of Anticoagulant‐Associated Bleeding

@article{Parks2017ScoringSF,
  title={Scoring Systems for Estimating the Risk of Anticoagulant‐Associated Bleeding},
  author={A. Parks and M. Fang},
  journal={Seminars in Thrombosis and Hemostasis},
  year={2017},
  volume={43},
  pages={514–524}
}
  • A. Parks, M. Fang
  • Published 2017
  • Medicine
  • Seminars in Thrombosis and Hemostasis
Abstract Anticoagulant medications are frequently used to prevent and treat thromboembolic disease. However, the benefits of anticoagulants must be balanced with a careful assessment of the risk of bleeding complications that can ensue from their use. Several bleeding risk scores are available, including the Outpatient Bleeding Risk Index, HAS‐BLED, ATRIA, and HEMORR2 HAGES risk assessment tools, and can be used to help estimate patients’ risk for bleeding on anticoagulants. These tools vary by… Expand
9 Citations

Paper Mentions

Interventional Clinical Trial
Cipherome's Lighthouse is a clinical decision support tool that incorporates a patient's pharmacogenetic information to determine therapeutic strategy, including determining… Expand
ConditionsBleeding, Ischemic Stroke, Myocardial Infarction, (+2 more)
InterventionDiagnostic Test
Observational Clinical Trial
The goal of this study is to predict and prevent adverse drug events by investigating the impact of genetic variants, demographics, and environmental factors in subjects status post… Expand
ConditionsAcute Coronary Syndrome, Ischemic Stroke, Myocardial Infarction, (+1 more)
Clinical Scoring Systems in Thrombosis and Hemostasis.
  • A. Cuker
  • Medicine
  • Seminars in thrombosis and hemostasis
  • 2017
  • 6
  • PDF
Pulmonary embolism: Care standards in 2018.
  • 9
Primary thromboprophylaxis for inpatients with advanced cancer
  • Highly Influenced
  • PDF

References

SHOWING 1-10 OF 82 REFERENCES
...
1
2
3
4
5
...